KURA Return on Tangible Equity | KURA ONCOLOGY, INC.

KURA ONCOLOGY, INC. (KURA) Return on Tangible Equity

2026-06-30: Return Tang Equity -612.78%.
2026-03-31: Return Tang Equity -273.05%.
2025-12-31: Return Tang Equity -160.03%.
2025-09-30: Return Tang Equity -89.42%.

Complete source-backed return tang equity history.

Available history: 2007-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-612.78%
2026-03-31	-273.05%
2025-12-31	-160.03%
2025-09-30	-89.42%
2025-06-30	-64.54%
2025-03-31	-49.91%
2024-12-31	-42.06%
2024-09-30	-46.62%
2024-06-30	-39.00%
2024-03-31	-33.28%
2023-12-31	-38.42%
2023-09-30	-33.25%
2023-06-30	-30.43%
2023-03-31	-34.78%
2022-12-31	-32.32%
2022-09-30	-32.28%
2022-06-30	-29.66%
2022-03-31	-27.76%
2021-12-31	-25.75%
2021-09-30	-23.21%
2021-06-30	-20.46%
2021-03-31	-17.25%
2020-12-31	-14.67%
2020-09-30	-26.54%
2020-06-30	-22.94%
2020-03-31	-33.67%
2019-12-31	-28.86%
2019-09-30	-26.27%
2019-06-30	-24.33%
2019-03-31	-39.97%
2018-12-31	-37.55%
2018-09-30	-31.56%
2018-06-30	-43.97%
2018-03-31	-34.06%
2017-12-31	-44.37%
2017-09-30	-35.91%
2017-06-30	-67.89%
2017-03-31	-56.66%
2016-12-31	-48.46%
2016-09-30	-41.92%
2016-06-30	-36.91%
2016-03-31	-32.57%
2015-12-31	-27.56%
2015-09-30	-42.78%
2015-06-30	-23.26%
2015-03-31	-9.21%
2014-12-31	0.90%
2014-09-30	20.16%
2014-06-30	20.89%
2014-03-31	21.90%
2013-12-31	23.08%
2013-09-30	24.97%
2013-06-30	26.28%
2013-03-31	27.55%
2012-12-31	28.65%
2012-09-30	30.97%
2012-06-30	33.63%
2012-03-31	37.13%
2011-12-31	39.75%
2011-09-30	43.79%
2011-06-30	46.15%
2011-03-31	34.17%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-160.03%
2024-12-31	-42.06%
2023-12-31	-38.42%
2022-12-31	-32.32%
2021-12-31	-25.75%
2020-12-31	-14.67%
2019-12-31	-28.86%
2018-12-31	-37.55%
2017-12-31	-44.37%
2016-12-31	-48.46%
2015-12-31	-27.56%
2014-12-31	0.90%
2013-12-31	23.08%
2012-12-31	28.65%
2011-12-31	39.75%
2010-12-31	54.63%
2009-12-31	107.53%
2008-12-31	-2401.64%
2007-12-31	-42.76%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19
Corvus Pharmaceuticals, Inc. (CRVS)	United States	$0.994B	-23.25
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
Janux Therapeutics, Inc. (JANX)	United States	$1.019B	-9.15
Pacira BioSciences, Inc. (PCRX)	United States	$1.020B	69.03
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.031B	-5.43
Apnimed, Inc. (APMD)	United States	$0.899B
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25
Savara Inc (SVRA)	United States	$1.044B	-9.10
Theravance Biopharma, Inc. (TBPH)		$0.885B	16.40